$183 Million is the total value of Tavio Capital LLC's 8 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 300.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ABC | New | AMERISOURCEBERGEN CORP | $35,323,000 | – | 384,697 | +100.0% | 19.27% | – |
UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $26,862,000 | +18.3% | 236,979 | +15.8% | 14.66% | +58.6% |
CVS | New | CVS HEALTH CORP | $24,471,000 | – | 337,537 | +100.0% | 13.35% | – |
DVA | New | DAVITA INC | $15,110,000 | – | 209,130 | +100.0% | 8.24% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MOLINA HEALTHCARE INC | 13 | Q2 2020 | 29.6% |
CENTENE CORP DEL | 11 | Q2 2020 | 19.1% |
ANTHEM INC | 10 | Q2 2019 | 22.5% |
BOSTON SCIENTIFIC CORP | 9 | Q4 2019 | 20.9% |
RETROPHIN INC | 9 | Q1 2019 | 3.4% |
ZIMMER BIOMET HOLDINGS INC | 8 | Q2 2020 | 20.6% |
HUMANA INC | 8 | Q4 2019 | 37.8% |
UNIVERSAL HLTH SVCS INC | 8 | Q1 2019 | 14.7% |
HCA HEALTHCARE INC | 8 | Q1 2020 | 12.3% |
MCKESSON CORP | 7 | Q2 2020 | 23.1% |
View Tavio Capital LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2020-10-01 |
13F-HR | 2020-08-13 |
13F-HR | 2020-05-14 |
13F-HR | 2020-02-13 |
13F-HR | 2019-11-13 |
13F-HR | 2019-08-13 |
13F-HR | 2019-05-14 |
13F-HR | 2019-02-14 |
13F-HR | 2018-11-13 |
13F-HR | 2018-08-13 |
View Tavio Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.